Bupivicaine Hydrochloride Injection, Solution
Product Images NDC 51662-1456

Product Visual Gallery

This gallery contains 18 technical images submitted to the FDA as part of the official labeling for Bupivicaine Hydrochloride (NDC 51662-1456). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Boxed Warning (Boxed Warning)

A boxed warning text panel for Bupivacaine Hydrochloride injection solution 0.75% concentration. The text advises against use of the 0.75% concentration for obstetrical anesthesia due to reports of cardiac arrest with difficult resuscitation or death. It explains that cardiac arrest occurred after convulsions from systemic toxicity, likely from unintentional intravascular injection, and that this strength is reserved for surgical procedures requiring high muscle relaxation and prolonged effect.*

FDA Label Image

Description 1 (Description 1)

A table presenting concentrations of Bupivacaine Hydrochloride (0.25%, 0.5%, 0.75%) alongside their corresponding strengths in mg/mL (2.5, 5, and 7.5 respectively) and associated Sodium Chloride content in mg/mL (8.6, 8.1, 7.6 respectively).*

FDA Label Image

Description 2 (Description 2)

A data table presenting concentrations of Bupivacaine Hydrochloride (in mg/mL), Epinephrine 1:200,000 (in mcg/mL), and Sodium Chloride (in mg/mL) for three different Bupivacaine HCl solution percentages: 0.25%, 0.5%, and 0.75%. The table shows corresponding values for Bupivacaine Hydrochloride as 2.5, 5, and 7.5 mg/mL, respectively, with consistent Epinephrine at 5 mcg/mL and Sodium Chloride at 8.5 mg/mL across all concentrations.*

FDA Label Image

Dosage And Administration (Dosage And Administration)

A dosage table for Bupivicaine Hydrochloride injection solution listing recommended concentrations, dose volumes (mL), and corresponding milligram amounts for various block types including local infiltration, epidural, caudal, peripheral nerves, retrobulbar, sympathetic, dental, and test doses. Motor block effects are noted for some block types with descriptions such as complete, moderate to complete, or partial to moderate.*

FDA Label Image

How Supplied 1 (How Supplied 1)

A data table showing multiple National Drug Codes (NDC) for Bupivacaine Hydrochloride injection solutions with varying concentrations and packaging. It lists units of sale as trays of 25 single-dose or multiple-dose vials, with concentrations ranging from 0.25% to 0.75%, vial sizes from 10 mL to 50 mL, and pH values from 4.0 to 6.5.*

FDA Label Image

How Supplied 2 (How Supplied 2)

A data table listing different units of sale and concentrations for Bupivicaine Hydrochloride injection solutions. It shows various packaging types such as cartons and trays of single-dose teartop vials and cases of multiple-dose flitop vials in different quantities, alongside their respective concentrations in mg/mL and pH ranges.*

FDA Label Image

Hs Logo (How Supplied Logo)

FDA Label Image

Indications & Usage (Indications And Usage)

A data table listing various types of nerve blocks and their corresponding Bupivacaine Hydrochloride injection solution concentrations. It includes local infiltration, peripheral nerve block, retrobulbar block, sympathetic block, lumbar epidural, caudal, epidural test dose, and dental blocks with specified percentages and notes on epinephrine admixture for test dose and dental blocks.*

FDA Label Image

Logo (Logo)

FDA Label Image

Precautions (Precautions)

A data table categorizing various drug classes alongside example drugs. Classes listed include Nitrates/Nitrites, Local anesthetics, Antineoplastic agents, Antibiotics, Antimalarials, Anticonvulsants, and Other drugs. Each class column is paired with examples such as bupivacaine under Local anesthetics and phenobarbital under Anticonvulsants.*

FDA Label Image

Serialized Labeling (Serialized Labeling Example)

BUPIVICAINE HYDROCHLORIDE 0.5% (5 mg/mL) Injection, USP in a 30 mL single-use teartop vial. The label indicates the product is preservative-free and intended for nerve block, caudal, and epidural anesthesia but not for spinal anesthesia. Manufactured for Hospira, Inc., Lake Forest, IL, with distribution by HF Acquisition Co., LLC.*

FDA Label Image

Structure 1 (Structure 1)

Chemical structure of Bupivacaine Hydrochloride, showing the molecular arrangement including a piperidine ring, amide linkage, aromatic ring with methyl groups, and associated hydrochloride and water molecules.*

FDA Label Image

Structure 2 (Structure 2)

Chemical structure of Bupivacaine Hydrochloride showing the arrangement of hydroxyl groups and organic chains characteristic of the molecule.*

FDA Label Image

Vial Label Opt 1 (Vial Label Opt 1)

Label for Bupivacaine Hydrochloride Injection, USP 0.5% (5 mg/mL) in a 30 mL single-use teartop vial. The label indicates the product is preservative-free, intended for nerve block, caudal, and epidural anesthesia but not for spinal anesthesia. It includes manufacturer information (Hospira, Inc., Lake Forest, IL) and the NDC 0409-1162-19, with additional details on content and storage conditions.*

FDA Label Image

Vial Label Opt 2 (Vial Label Option 2)

BUPIVICAINE HYDROCHLORIDE Injection, USP 150 mg/30 mL (5 mg/mL) single-dose teartop vial label. Contains preservative-free solution for injection. Manufacturer is Hospira, Inc. The label cautions for removal of block, caudal and epidural anesthesia and notes the product is for spinal anesthesia and sterility. NDC 0409-1162-19 is visible on the vial.*

FDA Label Image

Vial Label Opt 3 (Vial Label Option 3)

BUPIVICAINE HYDROCHLORIDE Injection, USP 0.5% strength (150 mg/30 mL or 5 mg/mL) in a 30 mL single-use teartop vial. The label emphasizes preservative-free formulation for nerve block, caudal, and epidural anesthesia, with a caution that it is not for spinal anesthesia. Manufactured by Hospira, Inc.*

FDA Label Image

Vial Label Opt 4 (Vial Label Option 4)

Label for Bupivacaine Hydrochloride Injection, USP 0.5% (5 mg/mL), 30 mL single-dose teartop vial. The label indicates it is preservative-free with a total of 150 mg per 30 mL. It is intended for nerve block, caudal, and epidural anesthesia, but specifically not for spinal anesthesia. Distributed by Hospira, Inc., Lake Forest, IL. Additional formulation details and storage instructions are included along with a barcode.*

FDA Label Image

Vial Label Opt 5 (Vial Label Option 5)

Label for Bupivacaine Hydrochloride Injection, USP 0.5% (5 mg/mL) in a 30 mL single-dose teartop vial. The vial contains 150 mg per 30 mL solution. The label states it is preservative-free and intended for nerve block, caudal, and epidural anesthesia, but not for spinal anesthesia. Distributed by Hospira, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.